Literature DB >> 29485068

Delineation of Neck Clinical Target Volume Specific to Nasopharyngeal Carcinoma Based on Lymph Node Distribution and the International Consensus Guidelines.

Li Lin1, Yao Lu2, Xiao-Ju Wang3, Hui Chen4, Sha Yu4, Jiao Tian4, Guan-Qun Zhou1, Lu-Lu Zhang1, Zhen-Yu Qi1, Jiang Hu1, Jun Ma1, Ying Sun5.   

Abstract

PURPOSE: To establish the regional lymph node (LN) distribution probability map and draw the neck clinical target volume specific to nasopharyngeal carcinoma (NPC). METHODS AND MATERIALS: One thousand patients with pathologically proven NPC were enrolled from January 2010 to December 2011. The center point of the LNs with a minimal axial diameter of ≥4 mm was marked on a single treatment planning computed tomography scan. The neck LN levels I to X using the 2013 updated international consensus guidelines were also contoured. LN distribution probability maps and distribution curves were established. The relationships between the LN distribution and consensus guidelines were analyzed to propose modifications for clinical target volume boundaries specific to NPC.
RESULTS: A total of 10,651 LNs from 959 patients were marked. Based on the distribution of LNs and consensus guidelines, most of the LN levels defined in the 2013 updated consensus guidelines were confirmed to be comprehensive and applicable for NPC. However, for level Vb, 13.3% of cases (11 of 83) had LNs beyond the posteromedial border. For level VIIa (retropharyngeal LN), 1.5% of cases (12 of 819) had LNs above the cranial boundary, and 5 cases had LNs that emerged in the medial group. Moreover, we confirmed that no LN had been detected in certain areas of levels Ib, II, IVa, and Vc. Accordingly, a new level VIIc was proposed to include the medial group of retropharyngeal LNs, moderately extended boundaries for levels Vb and VIIa were recommended, and reduced boundaries are possibly adaptable for levels Ib, II, IV, and Vc.
CONCLUSIONS: Most LN levels in the 2013 updated consensus guidelines are comprehensive and applicable for NPC. We have proposed a new level VIIc to include a medial group of retropharyngeal LNs, recommended moderate extended boundaries for levels Vb and VIIa, and suggested that the boundaries for levels Ib, II, IV, and Vc might be reduced.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29485068     DOI: 10.1016/j.ijrobp.2017.11.004

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  A New Model for Predicting Hypothyroidism After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma.

Authors:  Liang Peng; Yan-Ping Mao; Cheng-Long Huang; Rui Guo; Jun Ma; Wei-Ping Wen; Ling-Long Tang
Journal:  Front Oncol       Date:  2020-09-25       Impact factor: 6.244

2.  Radiosensitivity-Related Genes and Clinical Characteristics of Nasopharyngeal Carcinoma.

Authors:  Yongmei Dai; Yue Zhang; Mi Yang; Liang Zhou; Hua Pan; Ting Xiao; Lu Yuan; Yuting Wu; Min Chen; Longhua Chen; Jian Guan
Journal:  Biomed Res Int       Date:  2020-11-22       Impact factor: 3.411

3.  Rare Metastasis to the Submandibular Gland in Oral Squamous Cell Carcinoma.

Authors:  Ping Zhou; Jing-Xin Chen; Yuan Zhou; Chen-Lu Lian; Bing Yan; San-Gang Wu
Journal:  Front Oncol       Date:  2021-11-26       Impact factor: 6.244

4.  Is a high-risk clinical target volume required? Evaluation of the dosimetric feasibility based on T staging.

Authors:  Xingxing Yuan; Chao Yan; Shiyi Peng; Zhiping Chen; Tianzhu Lu; Qiaoying Gong; Yang Qiu; Wenming Xiong; Fenghua Ao; Guoqing Li; Jingao Li; Ziwei Tu
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738

5.  Distribution of CD8 T Cells and NK Cells in the Stroma in Relation to Recurrence or Metastasis of Nasopharyngeal Carcinoma.

Authors:  Yi Li; Hui Dong; Yudi Dong; Qiaoyuan Wu; Ni Jiang; Qing Luo; Fang Chen
Journal:  Cancer Manag Res       Date:  2022-09-27       Impact factor: 3.602

6.  The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma.

Authors:  Ling-Long Tang; Yu-Pei Chen; Chuan-Ben Chen; Ming-Yuan Chen; Nian-Yong Chen; Xiao-Zhong Chen; Xiao-Jing Du; Wen-Feng Fang; Mei Feng; Jin Gao; Fei Han; Xia He; Chao-Su Hu; De-Sheng Hu; Guang-Yuan Hu; Hao Jiang; Wei Jiang; Feng Jin; Jin-Yi Lang; Jin-Gao Li; Shao-Jun Lin; Xu Liu; Qiu-Fang Liu; Lin Ma; Hai-Qiang Mai; Ji-Yong Qin; Liang-Fang Shen; Ying Sun; Pei-Guo Wang; Ren-Sheng Wang; Ruo-Zheng Wang; Xiao-Shen Wang; Ying Wang; Hui Wu; Yun-Fei Xia; Shao-Wen Xiao; Kun-Yu Yang; Jun-Lin Yi; Xiao-Dong Zhu; Jun Ma
Journal:  Cancer Commun (Lond)       Date:  2021-10-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.